|
PGAM5 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.527800E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.741600E-01 |
| Normal-vs-Stage2 |
2.293000E-01 |
| Normal-vs-Stage3 |
2.689200E-01 |
| Normal-vs-Stage4 |
4.218200E-01 |
| Stage1-vs-Stage2 |
2.965500E-02 |
| Stage1-vs-Stage3 |
6.480800E-01 |
| Stage1-vs-Stage4 |
8.763600E-01 |
| Stage2-vs-Stage3 |
3.289600E-02 |
| Stage2-vs-Stage4 |
7.724400E-02 |
| Stage3-vs-Stage4 |
8.605000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.015800E-01 |
| Normal-vs-AfricanAmerican |
7.711800E-01 |
| Normal-vs-Asian |
3.044800E-01 |
| Caucasian-vs-AfricanAmerican |
8.218000E-01 |
| Caucasian-vs-Asian |
6.289200E-01 |
| AfricanAmerican-vs-Asian |
5.826600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.398990E-01 |
| Normal-vs-Female |
7.194200E-01 |
| Male-vs-Female |
1.181440E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.406000E-01 |
| Normal-vs-Age(41-60Yrs) |
4.113200E-01 |
| Normal-vs-Age(61-80Yrs) |
8.552200E-01 |
| Normal-vs-Age(81-100Yrs) |
7.637200E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.664400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.394400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.970600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.013600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
9.429800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.498600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
6.932400E-01 |
| Classical-VS-Follicular |
9.725000E-01 |
| Classical-VS-Other |
9.374200E-02 |
| Classical-VS-Normal |
6.967000E-01 |
| Tall-VS-Follicular |
7.259000E-01 |
| Tall-VS-Other |
1.701390E-01 |
| Tall-VS-Normal |
5.150400E-01 |
| Follicular-VS-Other |
2.259200E-01 |
| Follicular-VS-Normal |
7.811400E-01 |
| Other-VS-Normal |
4.656200E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.130200E-01 |
| Normal-vs-N1 |
2.998400E-02 |
| N0-vs-N1 |
3.556300E-02 |
|
|
